Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Myint Aung, Win"'
Publikováno v:
Journal of Enterprise Information Management, 2013, Vol. 26, Issue 5, pp. 536-552.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/JEIM-07-2013-0045
Autor:
Kyaw Zin Thein, Thura Win Htut, Myat Min Han, Yin Mon Myat, Myint Aung Win, Ei Moe Phyu, Thein H. Oo
Publikováno v:
Blood. 140:10887-10888
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::668c27cc4a39f07f25e3d504fc277f16
https://doi.org/10.1182/blood-2022-165629
https://doi.org/10.1182/blood-2022-165629
Autor:
Kyaw Zin Thein, Thura Win Htut, Myat Min Han, Yin Mon Myat, Myint Aung Win, Ei Moe Phyu, Thein H. Oo
Publikováno v:
Blood. 140:7997-7998
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40015189eb10cc2c6cc9ebb6d1906c64
https://doi.org/10.1182/blood-2022-165666
https://doi.org/10.1182/blood-2022-165666
Publikováno v:
The American journal of emergency medicine. 36(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bac68dbd9a8190c13053fb79e27b147
https://pubmed.ncbi.nlm.nih.gov/27836313
https://pubmed.ncbi.nlm.nih.gov/27836313
Autor:
Myat Min Han, Patrick Chaftari, K. Jacobson, Imad El Majzoub, Aiham Qdaisat, Myint Aung Win, Sai Ching J. Yeung, Cielito C. Reyes-Gibby, Michael Prejean, Kyaw Zin Thein
Publikováno v:
Annals of emergency medicine. 73(1)
Study objective Cancer immunotherapy is evolving rapidly and is transforming cancer care. During the last decade, immune checkpoint therapies have been developed to enhance the immune response; however, specific adverse effects related to autoimmunit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68fb9ba5b428dc74b53735548350c30a
https://pubmed.ncbi.nlm.nih.gov/30243546
https://pubmed.ncbi.nlm.nih.gov/30243546
Publikováno v:
The American journal of emergency medicine. 35(7)
Background Ipilimumab (a monoclonal antibody against CTLA-4) and nivolumab (a humanized antibody against PD-1) target these immune checkpoint pathways and are used for treatment of melanoma and an increasing number of other cancers. However, they may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d644ea31b2d48a7a7fdb4d9e124f24a
https://pubmed.ncbi.nlm.nih.gov/28363614
https://pubmed.ncbi.nlm.nih.gov/28363614
Autor:
Myat Min Han, Mark Currie, Lukman Tijani, Kenneth Pendergrast, Kyaw Zin Thein, Donald P. Quick, Myint Aung Win, Nicholas D'Cunha, Ei Moe Phyu
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S242-S243
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ee3423d2a64f30268c6a3590dfd64c4
https://doi.org/10.1016/j.clml.2018.07.135
https://doi.org/10.1016/j.clml.2018.07.135
Autor:
Ei Moe Phyu, Prospero Cortorreal, Myint Aung Win, Lukman Tijani, Myat Min Han, Edward Griffin, Kyaw Zin Thein, Donald P. Quick
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S241-S242
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7780b840ccff057f05e7cffd41f89ccb
https://doi.org/10.1016/j.clml.2018.07.133
https://doi.org/10.1016/j.clml.2018.07.133
Autor:
Ei Moe Phyu, Anita Sultan, Thura Win Htut, Sriman Swarup, Nyein Htway Yu, Myat Min Han, Bradley J. Grant, Kyaw Zin Thein, Nimesh Adhikari, Myint Aung Win, Nicholas D'Cunha, Yin Mon Myat, Chandler Graf, Donald P. Quick
Publikováno v:
Blood. 134:5877-5877
Introduction: Chronic lymphocytic leukemia is the most prevalent adult leukemia in western countries. Phosphatidylinositol 3-kinase (PI3K) is a kinase protein involved in downstream signaling for the B-cell receptor signaling pathway and has been sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::893f4829b7ba7de6d6f0bcfd50f73642
https://doi.org/10.1182/blood-2019-123531
https://doi.org/10.1182/blood-2019-123531
Autor:
Thura Win Htut, Somedeb Ball, Myat Min Han, Ei Moe Phyu, Myint Aung Win, Anita Sultan, Donald P. Quick, Nicholas D'Cunha, Lukman Tijani, Kyaw Zin Thein, Ramesh Kumar Pandey, Aung M. Tun, Sriman Swarup, Fred Hardwicke
Publikováno v:
Blood. 134:3158-3158
Introduction: Management of newly diagnosed multiple myeloma (NDMM), which accounts for 1% of all cancers, is an area in dire need of therapeutic innovation. In recent years, the introduction of novel agents is one of the major advances in the manage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abdcb3d3be88c75599a3b345dc164415
https://doi.org/10.1182/blood-2019-123131
https://doi.org/10.1182/blood-2019-123131